|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
Lausanne,Vaud, Switzerland,CH
|
|
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology. These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and solid tumors, address significant unmet medical needs, and improve the lives of patients with cancer. Our mission is to confront cancer with the full potential of our science to bring unique, targeted therapies and hope to patients and their families.
|
ADC Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used ADC Therapeutics email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact ADC Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.